Gould Robert J's Form 4/A amendment
AmendedFulcrum Therapeutics, Inc. (FULC) · filed Feb 4, 2026
- Accession no.
- 0001193125-26-037606
- Filed
- Feb 4, 2026
- Trade date
- Jan 2, 2026
- Filing delay
- 33 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jan 6, 2026
This filing lists 1 non-derivative transaction. Open-market sales total $163.1K. It was filed 33 days after the trade.
This amendment replaces 0001193125-26-004572 (filed Jan 6, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gould Robert JCIK 0001577034 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Common Stock | SSaleDisposed | −15,000 | $10.87F2 | −$163,050 | 469,864 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2025.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.60 to $11.33, inclusive. The reporting person undertakes to provide to Fulcrum Therapeutics, Inc., any security holder of Fulcrum Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. This Form 4/A corrects the weighted average price indicated in the Form 4 submitted on January 6, 2026 from $11.8726 to $10.8726.
Referenced by the price of 1 transaction in Table I.